Surgi-Vision Intercept
This article was originally published in The Gray Sheet
Executive Summary
Miniaturized MRI coil for prostate applications is launched at RSNA meeting following FDA 510(k) clearance. The coil will be distributed by GEMS, along with the previously cleared Intercept urethra and esophagus micro coils (1"The Gray Sheet" Oct. 30, 2000, p. 18). The firm also has a 510(k) pending for a vascular application of the Intercept. Clinical data presented at RSNA from an in vivo feasibility animal study sponsored by Surgi-Vision showed no complications observed using a 0.032 inch Intercept coil for intracoronary imaging, despite the coil staying in the target artery for 4-6 hours